Print

Print


you're correct, Bob, my iCare pharmacist and I are looking into it.

-----Original Message----- 
From: Bob Allison
Sent: Thursday, April 03, 2014 6:04 AM
To: [log in to unmask]
Subject: Re: ISRADIPINE BEING TESTED FOR PARKINSON'S DISEASE

Nic  I am no expert but i think phase ii is intended to establish safety not 
effectiveness.  Once safety is establsihed then phase iii begins to see if 
effectiveness is improved.  Bob
---- Nic Marais <[log in to unmask]> wrote:
> http://www.viartis.net/parkinsons.disease/news/140402.htm
>
> A somewhat confusing article. If the phase ll tests showed no improvement,
> why bother with phase lll.
>
> Nic 62/20
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: 
> mailto:[log in to unmask]
> In the body of the message put: signoff parkinsn

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn 

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn